In view of the importance of the dysfunction of endothelium-mediated vasodilatation, including EDH-response in hypertension, application of activators of KCa2.3/KCa3.1 channels such as SKA-31 seem to be promising avenue in pharmacotherapy of hypertension. The gene discussed is KCNN3; the disease is Hypertension.